Reducing insulin doses during dialysis sessions, considering the absence of typical symptoms of hypoglycaemia and providing patients with snacks before meals are crucial considerations in optimizing glycaemic control and minimizing adverse events in this patient population. This evidence concerns the gene INS and Hypoglycemia.